• HOME
  • |
  • Maryland Department of Health and Mental Hygiene
  • |
  • COMMISSIONER LOGIN

MMCC   News and Updates  

 Maryland Medical Cannabis Commission Announces

102 Dispensary License Pre-Approvals

 

Baltimore, MD (December 9, 2016) – The Maryland Medical Cannabis Commission (“MMCC”) today announced the names of 102 Dispensary entities who have been awarded Stage One license pre-approvals from a total of 811 applications submitted for up to 109 available licenses statewide.  This marks the conclusion of this phase of the Grower, Processor, and Dispensary application process.  Each pre-awardee has 365 days from date of pre-approval to implement their operations.

Dr. Paul W. Davies, Chairman for the Maryland Medical Cannabis Commission stated, “These qualified entities will be on the front line providing medical cannabis to qualified patients in Maryland. They will have a tremendous responsibility in serving the legitimate needs of those patients that seek medical treatment.”  

The Maryland Medical Cannabis Commission’s Executive Director, Patrick Jameson stated, “These dispensaries will be the new face of the medical cannabis industry in Maryland, once final licenses are issued. The Commission has an expectation that these dispensaries will operate in an extremely professional manner.  Professional business operations will provide reassurance to the general public that these companies will have a positive impact on their communities.  The Commission will tightly regulate these dispensaries and looks forward to a productive working relationship with their management and staff.”  


Pursuant to COMAR requirements, the Commission was tasked to recommend pre-approval of up to two licensed Dispensaries per Senatorial District, other than the number of licensed grower dispensary facilities located in the Senatorial District.  The full Commission voted unanimously on 92 Dispensary applications for pre-approvals, as well as 10 pre-approvals associated with pre-approved Growers, for a total of 102.  Two Senatorial Districts had only 1 pre-approval for those Districts and the remaining Districts were awarded 2 pre-approvals. By regulation, a party is only permitted to have an interest in one license in the State of Maryland.

All 10 Grower pre-awardees who submitted a separate Dispensary application were awarded a Dispensary pre-approval. Each Grower-associated Dispensary application was evaluated and scored on its own separate merit, as with the remaining 92 pre-approvals.

MMCC commissioned the Regional Economic Studies Institute (“RESI”), a division of Towson University, to coordinate the review of the Dispensary applications by subject matter experts and to utilize the same process as used for the Grower and Processor applications, including compiling the scores and application rankings.  The Commissioners reviewed blinded applications which were redacted as to the applicant names, entity names, and locations, and used a Nobel Prize winning mathematical algorithm, most famously used by the “National Resident Matching Program”, to place applicants into Senatorial Districts, using both the applicant’s score and District preferences.  All applicants, including those who did not receive pre-approvals, were notified today as to the status of their application via email and US mail.

The pre-approved Dispensary entities will continue on to Stage Two of the approval process, which will include undergoing criminal background investigations, financial due diligence, and compliance inspections by the MMCC, as well as completing regulatory requirements, raising capital, securing local zoning approvals, and construction of facilities. The Commissioners will vote for licensure in a public meeting once compliance with the regulatory requirements is complete. 

 

Entity Name                                                                   District

Advanced Alternative Therapies LLC

30

AGG Wellness LLC

42

Allegany Medical Marijuana Dispensary

1

Alternative Medicine Maryland LLC

32

AltPharm LLC

26

AmediCanna Dispensary LLC

12

B1 Earthgroup Inc.

14

Bethesda Biomedical Inc.

22

Blair Wellness Center LLC

43

Bloomworks Wellness LLC

3

Blu Pharms LLC

21

Blue Mountain LLC

34

Blue Ridge Wellness LLC

8

Budding Rose LLC

16

Cannabus LLC

15

CannaMD LLC

45

CannaPharmacy Maryland LLC

47

Cannavations MD LLC

11

Charm City Medicus LLC

6

Charm City Relief Partners LLC

44

Chesacanna Inc.

11

Chesapeake Alternatives LLC

16

Chesapeake Apothecary

28

Chesapeake Health Sciences

7

Chesapeake Integrated Health Institute LLC

40

Columbia Care MD LLC

18

Compassionate Herbal Alternatives Inc.

25

CWS LLC

42

DLD Enterprises Inc

5

Durjaya LLC

33

Euphoria Wellness Maryland LLC

4

Evolution Wellness LLC

30

Farmalogics Health & Wellness LLC

9

Four Green Fields LLC

35

Freestate Partners LLC

13

G&J Pharmaceuticals LLC

29

Gina Dubbe

12

GPD LLC

32

GreenLabs Inc.

46

GreenMart of Maryland

6

GTI Maryland LLC

20

H&G Maryland LLC

41

Hallaway LLC

45

Herbiculture Inc.

14

Hippocratic Growth LLC

36

Jenny’s of Maryland I LLC

24

Jova Wellness Center

26

K&R Holdings Inc.

4

LinLar LLC

24

LMS Wellness BLLC

8

Maryland Alternative Relief Inc.

19

Maryland Earthworks Inc.

28

Maryland Health & Wellness Inc.

2

Maryland Medical Cannabis Co. LLC (M2C2 HerbaFi)

20

Maryland Natural Treatment Solutions LLC

31

Maryland Physician Partners LLC

31

Maryland Wellness Access LLC

13

MaryLeaf LLC

39

MCNA Wellness LLC

27

Medical Products and Services Inc.

43

Meshow LLC

7

Metropolitan Medicinals LLC

25

MGTM LLC

33

MI Dispensary

39

Mikran LLC

15

Mission Maryland LLC

44

MMRC

10

MyBond LLC

5

Nature Care & Wellness LLC

35

OC Botanicals LLC

38

Our Community Wellness & Compassionate Care Center Inc.

23

PalliaTech Maryland LLC

10

Peake ReLeaf LLC

17

Peninsula Alternative Health LLC

37

PharmaCann LLC

18

PharmKent LLC

36

Positive Energy LLC

38

Premium Medicine of Maryland LLC

19

Pure Hana Synergy LLC

21

Pure Life Medical Inc.

46

Revolution Maryland Retail LLC

34

Southern Maryland Relief LLC

29

Sugarloaf Enterprises

17

The Apothecary LLC

1

The SENTEL Group LLC

23

Three Creeks Dispensary

27

Tilstar LLC

37

Time for Healing LLC

22

Town Center Wellness LLC

47

Trilogy Wellness of Maryland LLC

9

WadeWomen LLC-Dr. Dot’s

40

Wellness Institute of Maryland

3

 

Pre-Approved Growers Granted Dispensary Pre-Approvals:

 

Curio Dispensary BC LLC

42

Doctors Orders Maryland LLC

46

Freestate Wellness LLC

13

Harvest of Maryland

16

HMS Health LLC

17

Holistic Industries LLC

18

Kind Therapeutics USA LLC

30

Maryland Compassionate Care & Wellness LLC

17

MaryMed LLC

21

Temescal Wellness of Maryland LLC

11

 

SENATORIAL DISTRICTS IN MARYLAND*

DISTRICT 1 (Allegany, Garrett & Washington Counties)

DISTRICT 2 (Washington County)

DISTRICT 3 (Frederick County)

DISTRICT 4 (Carroll & Frederick Counties)

DISTRICT 5 (Carroll County)

DISTRICT 6 (Baltimore County)

DISTRICT 7 (Baltimore County & Harford County)

DISTRICT 8 (Baltimore County)

DISTRICT 9 (Carroll & Howard Counties)

DISTRICT 10 (Baltimore County)

DISTRICT 11 (Baltimore County)

DISTRICT 12 (Baltimore County & Howard County)

DISTRICT 13 (Howard County)

DISTRICT 14 (Montgomery County)

DISTRICT 15 (Montgomery County)

DISTRICT 16 (Montgomery County)

DISTRICT 17 (Montgomery County)

DISTRICT 18 (Montgomery County)

DISTRICT 19 (Montgomery County)

DISTRICT 20 (Montgomery County)

DISTRICT 21 (Anne Arundel & Prince George's Counties)

DISTRICT 22 (Prince George's County)

DISTRICT 23 (Prince George's County)

DISTRICT 24 (Prince George's County)

DISTRICT 25 (Prince George's County)

DISTRICT 26 (Prince George's County)

DISTRICT 27 (Calvert, Charles & Prince George's Counties)

DISTRICT 28 (Charles County)

DISTRICT 29 (Calvert & St. Mary's Counties)

DISTRICT 30 (Anne Arundel County)

DISTRICT 31 (Anne Arundel County)

DISTRICT 32 (Anne Arundel County)

DISTRICT 33 (Anne Arundel County)

DISTRICT 34 (Harford County)

DISTRICT 35 (Cecil & Harford Counties)

DISTRICT 36 (Caroline, Cecil, Kent & Queen Anne's Counties)

DISTRICT 37 (Caroline, Dorchester, Talbot & Wicomico Counties)

DISTRICT 38 (Somerset, Wicomico & Worcester Counties)

DISTRICT 39 (Montgomery County)

DISTRICT 40 (Baltimore City)

DISTRICT 41 (Baltimore City)

DISTRICT 42 (Baltimore County)

DISTRICT 43 (Baltimore City)

DISTRICT 44 (Baltimore City & Baltimore County)

DISTRICT 45 (Baltimore City)

DISTRICT 46 (Baltimore City)

DISTRICT 47 (Prince George's County) 

*http://msa.maryland.gov/msa/mdmanual/05sen/html/sendist.html 

 

A Letter from the Chairman of the Maryland Medical Cannabis Commission:

I am writing in response to a recent Washington Post news article, in which the Maryland Attorney General’s office made public statements regarding the Maryland Medical Cannabis Commission’s licensing process. The advice given to a client by its lawyer should be complete, confidential and thorough. 

When drafting the original law for issuing licenses to grow, process, and dispense medicinal cannabis in the State of Maryland, the Commission initially took every step possible to include racial diversity as a weighted component of the regulations.  The specific legislative intent required the Commission to, “actively seek to achieve racial, ethnic, and geographic diversity when licensing medical marijuana growers; and encourage applicants who qualify as a minority business enterprise...” Health-General, Annotated Code of Maryland, sections 13-3306(a)(i)(1).  

The Commission deliberately supported this language in the original statutory language because of a strong belief that minority inclusion is of paramount importance to this new industry. After requesting the customary legal review, the Commission subsequently received thorough and complete legal advice from the Maryland Office of the Attorney General stating that race-based mandates would violate the United States and Maryland Constitutions. Based on the Attorney General’s opinion to Delegate Chris West concerning this issue, the Commission found it necessary to remove the provisions from the final regulations.  

To be specific, an opinion letter dated March 13, 2015 to Delegate Chris West, written by Assistant Attorney General Kathryn M. Rowe, stated:

“The provisions of Croson and Fisher apply to ethnicity in the same way as race.  They do not, however, apply to geographically conscious programs.  Thus, the law should be read to have full force to the extent that it requires the Commission to seek geographic diversity to the extent possible [emphasis added].  Moreover, it is not unconstitutional to encourage businesses of any type, including those in the minority business enterprise program, to apply to participate in any type of government program.  Constitutional limits, however, would prevent the Commission from conducting race- or ethnicity conscious licensing in the absence of a disparity study showing past discrimination in similar programs.  I am aware of no study that would cover grower or dispensary licenses, or even licensing in general [emphasis added].  Most State licensing programs license everyone who meets the licensing qualifications, and thus would not give rise to the ability to pick some and not others.  As a result, the efforts of the Commission to seek racial and ethnic diversity among growers and dispensaries would have to be limited to broad publicity given the availability of the licenses and encouragement of those from various groups.”

The Attorney General’s Office at the time of that opinion admitted that there was no such disparity study known to exist nor did they promulgate other novel remedies.  

I, as the Chairman, along with all of the other Commissioners, followed strict regulations and guidelines defined at the beginning of the application process as required by law, to ensure a fair and objective selection process. The Commission enlisted Towson University’s Regional Economic Studies Institute (“RESI”) to conduct the evaluation of applicants through a double-blinded process. Due to the Attorney General’s opinion and the change in the legislative language as noted above, there were no requirements to disclose race on the application.  In addition, all identifying information such as individual, entity, investor, and employee names was redacted.  The Commissioners voted only on coded and redacted RESI applications.

We all know that this process was extremely competitive. The Commission received 145 Grower applications, but could only grant up to 15 Grower pre-approvals because of statutory limitations implemented by the legislature.  Additionally, we realize that this emerging industry creates numerous possibilities for growth and economic opportunity for many in Maryland.  We take our responsibility extremely seriously to ensure that qualifying patients, the sick and suffering of Maryland, are provided with a process to receive the most safe and effective medicine possible.  We remain dedicated to this mission and are confused to see the Attorney General’s office recent public statements regarding their position.  

Finally, I would like to reiterate that the Commission is committed to seeking and promoting racial diversity and minority inclusion.  We believe that diversity is in the best interest of the industry and an important responsibility. The Commission will continue to work with the legislature to help solve these complex problems.

Paul Davies, M.D., Chair
Maryland Medical Cannabis Commission 

 


 

August 24, 2016

Announcement Regarding Commission Rankings for Grower and Processor Applicants  

The Maryland Medical Cannabis Commission is releasing the 1 through 20 Grower and 1 through 30 Processor names with their Commission rankings (see list below). There were many highly-qualified Grower and Processor applicants; however, the Commission was limited to granting up to 15 Grower pre-approvals due to statutory limitations issued by the legislature.  The Commission temporarily limited the number of Processor pre-approvals to 15 due to resource management. Five extra Grower applications and 15 extra processor applications were voted on to be pre-approved should any of the pre-approved entities not result in final licensure. Beginning June 1, 2018, the Commission will review supply and demand and may be able to issue more licenses if necessary, based on the need.  

Towson University’s Regional Economic Studies Institute (“RESI”) was enlisted by the Commission to review, evaluate and rank the applications received from interested applicants. RESI employed and the Commission adopted a double-blind review process. The top ranked 20 Grower and top ranked 30 Processor applications were voted on only by coded number prior to the de-coding process. The other RESI rankings (rankings from the twenty-first ranked application to the 145th application for Grower, and thirty-first to 124th for Processors) have not been de-coded nor voted on by the Commission.

As a reminder, the pre-approved entities announced on August 15 have not been issued licenses.  They will undergo extensive background checks, financial due diligence, and inspections in the next phase of a two-stage approval process.

Commission Grower Rankings

  1.    Green Leaf Medical LLC   Frederick County
  2.    Doctors Orders Maryland LLC   Dorchester County
  3.    Maryland Compassionate Care and Wellness LLC   Carroll County
  4.    Freestate Wellness LLC   Howard County
  5.    Kind Therapeutics USA LLC   Washington County
  6.    SunMed Growers LLC   Cecil County
  7.    HMS Health LLC   Frederick County
  8.    Harvest of Maryland   Washington County
  9.    Curio Cultivation LLC   Baltimore County
  10.  Grow West MD LLC   Garrett County
  11.  ForwardGro LLC   Anne Arundel County
  12.  MaryMed LLC   Dorchester County
  13.  Temescal Wellness of Maryland LLC   Baltimore City
  14.  Holistic Industries LLC   Prince George’s County
  15.  Shore Naturals Rx LLC   Worcester County
  16.  MD Cultivation and Processing LLC   Frederick County
  17.  GTI Maryland LLC   Washington County
  18.  Kind Earth Medicinals   Montgomery County
  19.  Maryland Natural Treatment Solutions   Caroline County
  20.  Mazey Farms LLC   Garrett County

 

Commission Processor Rankings

  1.    Curio Manufacturing LLC
  2.    AFS Maryland LLC
  3.    Maryland Compassionate Care and Wellness LLC
  4.    PharmaCulture LLC
  5.    Blair Wellness Center LLC
  6.    Seven Points Agro-Therapeutics
  7.    Chesapeake Alternatives LLC
  8.    Doctors Orders Maryland LLC
  9.    Pro Green Medical LLC
  10.  Rosebud Organics LLC
  11.  Temescal Wellness of Maryland LLC
  12.  Kind Therapeutics USA LLC
  13.  FGM Processing LLC
  14.  Holistic Industries LLC
  15.  MaryMed LLC
  16.  Citiva Maryland LLC
  17.  ForwardExtracts LLC
  18.  PharmaKent LLC
  19.  HMS Health
  20.  Herbiculture Inc
  21.  GTI Maryland
  22.  Freestate Partners LLC
  23.  Harvest of Maryland
  24.  Wellness Institute of Maryland
  25.  Chesapeake Apothecary LLC
  26.  Maryland Earthworks LLC
  27.  Healthy Extracts LLC
  28.  Chesacanna Inc
  29.  Mikran LLC
  30.  NH Medicinal

 

Download Announcement Regarding Commission Rankings for Grower and Processor Applicants ( 08/24/2016)


Natalie M. LaPrade Maryland Medical Cannabis Commission Announces 
Grower and Processor License Pre-Approvals

Baltimore, MD (August 15, 2016) -The Natalie M. LaPrade Maryland Medical Cannabis Commission (“MMCC”) today announced the names of the 15 Growers and 15 Processors who have been awarded Stage One license pre-approvals. The Commission’s actions mark a giant step forward for the medical cannabis program in Maryland.

Dr. Paul W. Davies, Chairman of the Maryland Medical Cannabis Commission stated, “I’m excited that we have a great number of outstanding companies willing to help sick people in Maryland.” The potential licensees comprise a diverse group of principals, executives and corporate officers including Maryland residents associated with long-time established Maryland businesses, entrepreneurs, women and minority-operated enterprises. Seven of the Processors are affiliated with Growers who received Stage One pre-approvals.

The Commissioners’ selections for Grower entities and locations are:

  Curio Cultivation LLC   Baltimore County
  Doctors Orders Maryland LLC   Dorchester County
  Forward Gro LLC   Anne Arundel County
  Freestate Wellness LLC   Howard County
  Green Leaf Medical LLC   Frederick County
  Grow West MD LLC   Garrett County
  Harvest of Maryland LLC   Washington County
  HMS Health LLC   Frederick County
  Holistic Industries LLC   Prince George’s County
  Kind Therapeutics USA LLC   Washington County
  Maryland Compassionate Care and Wellness LLC   Carroll County
  MaryMed LLC   Dorchester County
  Shore Natural Rx LLC   Worcester County
  SunMed Growers LLC   Cecil County
  Temescal Wellness of MD LLC   Baltimore City

 

 The Processor entities and locations are:

  AFS Maryland LLC   Wicomico County
  Blair Wellness Center LLC   Worcester County
  Chesapeake Alternatives LLC   Queen Anne’s County
  Curio Manufacturing LLC   Baltimore County
  Doctors Orders Maryland LLC   Dorchester County
  FGM Processing LLC   Charles County
  Holistic Industries LLC   Prince George’s County
  Kind Therapeutics USA LLC   Washington County
  Maryland Compassionate Care and Wellness LLC   Carroll County
  MaryMed LLC   Dorchester County
  Pharmaculture Corporation   Allegany County
  Pro Green Medical LLC   Frederick County
  Rosebud Organics LLC   Montgomery County
  Seven Points Agro-Therapeutics LLC   Prince George’s County
  Temescal Wellness of MD   Baltimore City

 


The locations of the Growers and Processors span 16 counties and Baltimore City (see map), including Allegany, Anne Arundel, Baltimore, Carroll, Cecil, Charles, Dorchester, Frederick, Garrett, Howard, Montgomery, Prince George’s, Queen Anne’s, Washington, Wicomico and Worcester. Many Grower applicants who were highly qualified were not pre-approved due to statutory limitations on the number of growers.

The Maryland Medical Cannabis Commission’s Executive Director, Patrick Jameson stated, “Now that the Commissioners have made their selections, the real work begins for these companies. We will implement a rigorous Stage Two background and financial due diligence process for these entities prior to issuing a license.  A pre-approval is not a license. I truly look forward to facilitating this nascent state wide industry and working with local, city, and county jurisdictions and with the principals of these organizations.” The Commissioners will vote for licensure once compliance with the regulatory requirements is complete.

The Growers will cultivate a variety of strains ranging in cannabinoid content from a low to high spectrum of Tetrahydrocannabinol (THC) and Cannabidiol (CBD), and the Processors will be manufacturing a wide variety of cannabis-infused products containing high and low CBD and THC extracts and in a variety of modes of administration. These pharmaceutical grade products will include oral forms such as oils, pills, capsules, tinctures; sublingual sprays; inhaled products and topical forms such as ointments, salves, and transdermal patches.

MMCC also commissioned the Towson University, Regional Economic Studies Institute “RESI” to coordinate the review of the Dispensary Applications by subject matter experts and to utilize the same process as for the Grower and Processor applications such as compiling the scores and application rankings. The Commissioners will review and vote on the Dispensaries (two per Senatorial district and potentially 15 additional for Growers who wish to be vertically integrated) with medicine tentatively becoming available by the summer of 2017.

Dr. Davies continued, “While we are aware there is a public interest in the rankings of the Grower and Processor applications, the rankings were merely used as an organizational tool.  The Commission will list the entities in alphabetical order. All of the chosen business entities have an equal opportunity to complete the licensing process.  At this stage, I am very happy with the Commissioners' choices."

Maryland received 145 grower applications, 124 processor applications and 811 dispensary license applications. Again, MMCC commissioned RESI to contract with third-party subject matter experts from around the United States to evaluate the applications using a double-blinded process. RESI assigned unique identifying numbers to each application prior to evaluation and review by subject matter experts and Commissioners. Application content comprised text and supporting documents redacted of all identifying information such as individual or entity applicant names and locations.  Once evaluated and scored by the subject matter experts, RESI compiled the scores and ranked the applications. The scored and ranked redacted Grower and Processor applications were then provided to Commissioners for review and final selection.

The 15 Grower and Processor potential licensees will continue on to Stage Two of the approval process, which will include extensive financial due diligence and background investigations by the MMCC of all those named in the original application and any other principals. Each entity that was issued a pre-approval will have 365 days from date of notification to complete all necessary steps to obtain a formal license and to request final inspection by the Commission. These steps include completing regulatory requirements, raising capital, acquiring real estate, securing local zoning approvals, construction of facilities, installation of equipment, and the hiring and training of staff. 

All applicants, including those who did not receive pre-approvals, were notified as to the status of their application by email and U.S. mail today.

See Map of Agricultural Regions of Maryland 

Download Press Release

The Natalie M. LaPrade Maryland Medical Cannabis Commission develops policies, procedures and regulations to implement programs that ensure medical cannabis is available to qualifying patients in a safe and effective manner. The Commission oversees all licensing, registration, inspection and testing measures pertaining to Maryland’s medical cannabis program and provides relevant program information to patients, physicians, growers, dispensers, processors, testing laboratories, caregivers and the general public.

  


 

GOVERNOR HOGAN ANNOUNCEMENT:  NEW EXECUTIVE DIRECTOR OF THE MARYLAND MEDICAL CANNABIS COMMISSION

Governor Hogan has announced the appointment of Patrick Jameson as the new Executive Director of the Maryland Medical Cannabis Commission, effective April 25, 2016. Mr. Jameson has a diverse background in public safety, business development and executive management. Mr. Jameson served in the Maryland State Police from 1987 to 1999 in the Special Operations and Criminal Investigation Divisions, and as President of the State Law Enforcement Officers Labor Alliance. He has previously worked in the Maryland Office of the Attorney General and is a former National Director of Homeland Security for Oracle Corporation.  Mr. Jameson holds a MBA from the Johns Hopkins University.

 


 

Grand Rounds were held at the Anne Arundel Medical Center on January 20, 2016. Commissioners Eric Sterling and Deborah Miran presented on Medical Cannabis In Maryland.  To view Commissioner Sterling's presentation, click here Eric Sterling Presentation

 


Cannabinoids reduce inflammation pain in sickle anemia

Researchers showed that cannabinoids ameliorate mast cell activation, inflammation and neurogenic inflammation in sickle mice via both cannabinoid receptors 1 and 2. Thus, cannabinoids influence systemic and neural mechanisms, ameliorating the disease pathobiology and pain in mice with sickle cell anemia. 
University of Minnesota, USA.

Vincent L, et al. Haematologica. 2015 Dec 24. [in press] 

Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment

Congress Quietly Ends Federal Ban On Medical Marijuana   12/22/15

Newsweek article: "In States With Medical Marijuana, Painkiller Deaths Drop by 25%"


Conferences and Seminars 

Commissioners Eric Sterling and Deborah Miran spoke on October 08,2015 at The University of Maryland Medical System. Click on their names to download their presentations. 

Americans for Safe Access Program to Provide Training For Maryland Medical Cannabis Commission Compliance Inspectors 

The Natalie M. LaPrade Maryland Medical Cannabis Commission Contracts With Regional Economic Studies Institute at Towson University for Licensing Reviews

 

Medical Cannabis Comes to #MACoCon

At the MACo Summer Conference session entitled “Medical Cannabis Comes to Maryland” audience members received updates from members of the Natalie M. LaPrade Maryland Medical Cannabis Commission on state regulations for medical cannabis and on the implementation timeline and process.

“This is medicine. Medicine for sick people.” Panelists Hannah Byron, Executive Director of the the Maryland Medical Cannabis Commission, and Deborah Miran, Member of the Commission started the session by emphasizing the medical importance of cannabis and distinguishing it from its recreational counterpart. Miran presented on the science of the endocannabinoid system and the therapeutic properties of cannabis that help with a number of diseases ranging from mood and anxiety disorders to neuropathic pain, Huntington’s disease, leukemia and glaucoma to name a few.  Miran also shared data on the safety profile of cannabis noting that there is zero percent chance of a lethal dose as it would take a 70kg man to smoke 1,500 pounds in 15 minutes.

Byron then presented on the nuts and bolts of the Maryland Medical Cannabis Program. Starting first with background on the law that created the commission and granted its authority, Byron then delved into the pending regulations and details for implementation, including the overall licensing process, limits on the number of licenses, and authorized forms of cannabis (for instance leaf products converted into products such as ointments, vaporizable extracts and salves). In regards to growers and dispensers the overview included independent testing and facility inspections; types of growing premises; security requirements; and product packaging and labels.  Byron also discussed registration of patients, physicians, and the patient-physician relationship. Noting that there must be a bona fide patient-physician relationship and that patients will be limited to a 30 day supply with a written certification.  The presentation concluded with comments on state versus federal law, and physician protection.

Much discussion during the Q&A portion of the session centered on zoning requirements. The panelists assured audience members that any facility would have to meet all local planning and zoning requirements. The panelists also acknowledged banking issue faced by jurisdictions across the country and the push on Capitol Hill to address the problem.

The session was moderated by the Honorable John F. Barr, Commissioner, Washington County; First Vice President, Maryland Association of Counties and held from 1:00 pm – 1:45 pm on Thursday, August 13, 2015. This year’s MACo Summer Conference theme was “Energize. Mobilize. Capitalize.” For more information about MACo’s Summer Conference, please visit www.mdcounties.org/MACoCon.

 

Please continue to check the website for further updates and information. 


Last Updated: 1/20/2017